Client News
Roquefort Therapeutics plc – Notice of Annual General MeetingRoquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth oncology market, has today posted its Notice of Annual General Meeting to Shareholders. The Annual General Meeting is scheduled to take place at the offices of Axiom Ince Limited, Aldgate Tower, 2 Leman Street, London E1 8QN at 9.00 am on 29 June 2023.
The Notice of Annual General Meeting and Forms of Proxy can be downloaded from the Company’s corporate website at: https://www.roquefortplc.com/shareholder-documents
Notice of Annual General Meeting – 07:00:08 06 Jun 2023 – ROQ News article | London Stock Exchange
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
CLIENT AREA
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.